mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.2 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.2 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |